<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>32</volume>
<number>152</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of Antibiotic Sensitivity, Biofilm Formation Ability, and Prevalence of Extended-Spectrum Beta-Lactamase (ESBLs) in Clinically Isolates Escherichia coli and Klebsiella pneumoniae</title>
	<subject_fa>Life Science</subject_fa>
	<subject>Life Science</subject>
	<content_type_fa>مقاله پژوهشی</content_type_fa>
	<content_type>Original Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Background &amp; Objective:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;Extended-spectrum beta-lactamases (ESBLs) are enzymes in bacteria that resist many antibiotics. Detection of &lt;a name=&quot;_Hlk165045335&quot;&gt;ESBLs&lt;/a&gt; production is important as it&amp;#39;s a marker of colonization and potential transfer to other patients. &lt;/span&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;We studied the antibiotic susceptibility, biofilm formation capacity, and prevalence of ESBLs of opportunistic bacteria including &lt;i&gt;K. pneumoniae &lt;/i&gt;and&lt;i&gt; E. coli&lt;/i&gt;. The isolates capable of biofilm formation were analyzed among 100 &lt;i&gt;E. coli and&lt;/i&gt; 104 &lt;i&gt;K. pneumoniae&lt;/i&gt; isolates.&lt;/span&gt;&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;&amp;nbsp;Materials &amp; Methods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:9.0pt&quot;&gt;This&lt;b&gt; &lt;/b&gt;process involved collecting and identifying bacterial samples, testing antibiotic susceptibility, detecting &lt;a name=&quot;_Hlk165045433&quot;&gt;ESBLs&lt;/a&gt; phenotypes, and multidrug-resistance (MDR) isolates, assessing biofilm formation capability, and evaluating results through statistical analysis.&lt;span style=&quot;color:red&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&amp;nbsp;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;The susceptibility tests for discs were performed following the guidelines outlined by the Clinical Laboratory Standards Institute in 2023 (CLSI). &lt;i&gt;K. pneumoniae&lt;/i&gt; exhibits inherent resistance to ampicillin, while 80 (80%) strains of &lt;i&gt;E. coli&lt;/i&gt; have been reported to be resistant to ampicillin. Additionally, 50 &lt;i&gt;K. pneumoniae&lt;/i&gt; isolates and 41 &lt;i&gt;E. coli&lt;/i&gt; isolates were found capable of forming a biofilm. Seven of &lt;i&gt;E. coli&lt;/i&gt; (17.07%), and seven of &lt;i&gt;K. pneumoniae&lt;/i&gt; (14%) isolates could form a mighty biofilm. It was observed that the strongest resistance in the isolates that formed strong biofilm was related to tetracycline with 5 (7.2%) resistance in &lt;i&gt;K. pneumonia &lt;/i&gt;and 7 (7%) resistance in &lt;i&gt;E. coli&lt;/i&gt;. Furthermore, 47 (47%) of &lt;i&gt;E. coli&lt;/i&gt;, and 21 (20.2%) of &lt;i&gt;K. pneumoniae&lt;/i&gt; isolates were classified as ESBLs producers, and 52 (50%) &lt;i&gt;K. pneumoniae&lt;/i&gt; and 72 (72%) &lt;i&gt;E. coli&lt;/i&gt; isolates were classified as MDR.&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;Considering the role of biofilm in the transfer of genes, appropriate health policies, and the correct administration of effective antibiotics can help in prevention.&lt;/span&gt;&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Escherichia coli, Klebsiella pneumoniae, Antibiotic-resistant, Biofilm, ESBLs, MDR</keyword>
	<start_page>219</start_page>
	<end_page>225</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-5288-6&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Bahman</first_name>
	<middle_name></middle_name>
	<last_name>Mirzaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr.bahman.m@gmail.com</email>
	<code>5200319475328460089428</code>
	<orcid>5200319475328460089428</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Science, Zanjan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
